Prothena Corp Public (PRTA) FCF Margin (QoQ) (2012 - 2026)

Prothena Corp Public (PRTA) FCF Margin (QoQ) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Prothena Corp Public 458.45 Mn 170.25 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 -260,118.00
Mar 31, 2026 11.11 Mn
Dec 31, 2025 -10.93 Mn
Sep 30, 2025 -62,976.00
Jun 30, 2025 83,808.00
Mar 31, 2025 36,380.00
Dec 31, 2024 240,704.00
Sep 30, 2024 -467,126.00
Jun 30, 2024 14.63 Mn
Mar 31, 2024 -12.97 Mn
Dec 31, 2023 -1.67 Mn
Sep 30, 2023 114,774.00
Jun 30, 2023 105,318.00
Mar 31, 2023 -217,996.00
Dec 31, 2022 205,282.00
Sep 30, 2022 63,691.00
Jun 30, 2022 54,692.00
Mar 31, 2022 -130,349.00
Dec 31, 2021 -202,383.00
Sep 30, 2021 1,944.00